Literature DB >> 29744344

Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint.

Taizo Hibi1, Yasuhiko Sugawara1.   

Abstract

Entities:  

Year:  2018        PMID: 29744344      PMCID: PMC5934129          DOI: 10.21037/hbsn.2018.01.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

1.  Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center.

Authors:  Tan To Cheung; Wing Chiu Dai; Simon H Y Tsang; Albert C Y Chan; Kenneth S H Chok; See Ching Chan; Chung Mau Lo
Journal:  Ann Surg       Date:  2016-10       Impact factor: 12.969

Review 2.  The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals.

Authors:  Jose D Debes; Robert J de Knegt; Andre Boonstra
Journal:  Transplantation       Date:  2017-05       Impact factor: 4.939

3.  Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).

Authors:  Norihiro Kokudo; Kiyoshi Hasegawa; Masaaki Akahane; Hiroshi Igaki; Namiki Izumi; Takafumi Ichida; Shinji Uemoto; Shuichi Kaneko; Seiji Kawasaki; Yonson Ku; Masatoshi Kudo; Shoji Kubo; Tadatoshi Takayama; Ryosuke Tateishi; Takashi Fukuda; Osamu Matsui; Yutaka Matsuyama; Takamichi Murakami; Shigeki Arii; Masatoshi Okazaki; Masatoshi Makuuchi
Journal:  Hepatol Res       Date:  2015-01       Impact factor: 4.288

4.  Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: a potential game changer toward global standardization of care.

Authors:  Taizo Hibi; Yuko Kitagawa
Journal:  Hepatobiliary Surg Nutr       Date:  2017-06       Impact factor: 7.293

5.  Understanding surgical decision making in early hepatocellular carcinoma.

Authors:  Hari Nathan; John F P Bridges; Richard D Schulick; Andrew M Cameron; Kenzo Hirose; Barish H Edil; Christopher L Wolfgang; Dorry L Segev; Michael A Choti; Timothy M Pawlik
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

Review 6.  Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.

Authors:  Jeffrey Meyer; Amit G Singal
Journal:  Liver Transpl       Date:  2018-02-09       Impact factor: 5.799

7.  Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Richard M Ruiz; Goran B Klintmalm; Srinath Senguttuvan; Sander S Florman; Brandy Haydel; Maarouf Hoteit; Matthew H Levine; David D Lee; C Burcin Taner; Elizabeth C Verna; Karim J Halazun; Rita Abdelmessih; Amit D Tevar; Abhinav Humar; Federico Aucejo; William C Chapman; Neeta Vachharajani; Mindie H Nguyen; Marc L Melcher; Trevor L Nydam; Constance Mobley; R Mark Ghobrial; Beth Amundsen; James F Markmann; Alan N Langnas; Carol A Carney; Jennifer Berumen; Alan W Hemming; Debra L Sudan; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Abbas Rana; Michael L Kueht; Christopher M Jones; Thomas M Fishbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

8.  Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.

Authors:  Kohei Ishiyama; Hideki Ohdan; Masahiro Ohira; Hiroshi Mitsuta; Koji Arihiro; Toshimasa Asahara
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

9.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Authors:  Riad Salem; Andrew C Gordon; Samdeep Mouli; Ryan Hickey; Joseph Kallini; Ahmed Gabr; Mary F Mulcahy; Talia Baker; Michael Abecassis; Frank H Miller; Vahid Yaghmai; Kent Sato; Kush Desai; Bartley Thornburg; Al B Benson; Alfred Rademaker; Daniel Ganger; Laura Kulik; Robert J Lewandowski
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

10.  Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

Authors:  Edward K Geissler; Andreas A Schnitzbauer; Carl Zülke; Philipp E Lamby; Andrea Proneth; Christophe Duvoux; Patrizia Burra; Karl-Walter Jauch; Markus Rentsch; Tom M Ganten; Jan Schmidt; Utz Settmacher; Michael Heise; Giorgio Rossi; Umberto Cillo; Norman Kneteman; René Adam; Bart van Hoek; Philippe Bachellier; Philippe Wolf; Lionel Rostaing; Wolf O Bechstein; Magnus Rizell; James Powell; Ernest Hidalgo; Jean Gugenheim; Heiner Wolters; Jens Brockmann; André Roy; Ingrid Mutzbauer; Angela Schlitt; Susanne Beckebaum; Christian Graeb; Silvio Nadalin; Umberto Valente; Victor Sánchez Turrión; Neville Jamieson; Tim Scholz; Michele Colledan; Fred Fändrich; Thomas Becker; Gunnar Söderdahl; Olivier Chazouillères; Heikki Mäkisalo; Georges-Philippe Pageaux; Rudolf Steininger; Thomas Soliman; Koert P de Jong; Jacques Pirenne; Raimund Margreiter; Johann Pratschke; Antonio D Pinna; Johann Hauss; Stefan Schreiber; Simone Strasser; Jürgen Klempnauer; Roberto I Troisi; Sherrie Bhoori; Jan Lerut; Itxarone Bilbao; Christian G Klein; Alfred Königsrainer; Darius F Mirza; Gerd Otto; Vincenzo Mazzaferro; Peter Neuhaus; Hans J Schlitt
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.